2-(Hydroxymethyl)-1-oxaspiro[5.5]undecan-9-one, 98%, 250mg

(1R,4S,5R,6R)-5,6-Bis(diphenylphosphaneyl)bicyclo[2.2.1]hept-2-ene, 98%, 1g

5-(4-Fluoro-phenyl)-[1,2,4]triazin-3-ylamine, 250mg

2-Ethylhexyl Acrylate Monomer (stabilized with MEHQ)>99.0%(GC)25mL

Pointes de pipettes Mμlti® OneTouch 0,1-20 μl, Boîte en carton (couvercle coulissant), Stérile, 960 Pièces

8-Oxa-2-azaspiro[4.5]decan-3-one, 95.0%, 250mg

2-(Furfurylthio)ethylamine>98.0%(GC)(T)5g

6-Bromopyridine-3,4-diamine, 95.0%, 250mg

N-(3-Chloro-phenyl)-phthalamic acid, 95.0%, 500mg

7-Bromo-1-methyl-1H-benzo[d][1,2,3]triazole, 98%, 100mg

2,4-Dibromo-5-methylthiazole, 95.0%, 10g

(R)-2-AMINO-3-(TETRAHYDRO-2H-PYRAN-4-YL)PROPANOIC ACID HYDROCHLORIDE, 95.0%, 1g

Polydimethylsiloxane, trimethylsiloxy terminated cSt 10, 3kg